{"name":"Cartesian Therapeutics","slug":"cartesian-therapeutics","ticker":"","exchange":"","domain":"cartesian.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBjeTZBSnVKa2t0ZVpLd2prb2N1WU9LZE5ObEZrdVBVSHpnNnRud2kwWnZvb2dMNXpYOVR6dzJRSmt2U3dUS21pczhIeDdZaTRRN1VFVmJrcjhJQUwxb2xfWEU1TWJtUk9KVXA2ZEdn?oc=5","date":"2026-04-07","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Cartesian (RNAC) - Stock Titan","headline":"If You Invested $1,000 in Cartesian (RNAC)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"pipeline","source":"simplywall.st","summary":"Insiders' US$1.73m Investments In Red Following Cartesian Therapeutics' US$29m Dip In Market Value - simplywall.st","headline":"Insiders' US$1.73m Investments In Red Following Cartesian Therapeutics' US$29m Dip In Market Value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxNU2tzSlduWlBhZ25xZTJHX0pWX0dYcFNSRHBuWVkxLUYxN0c2WENueFE5RWtGaS1Zdk14eVhJOVFHR29RNE92eVZuakl3d1BlSmJsRUxSa0pseThZZ1QyMXpUanc0OUxUSUdOWVB4RHpsdUVLSnRWckQ3Q01HMG5yVnIwZE1Ld1RDMTJGUEpWWnh4dWN4TWVUOTF3U3BHVDY5ZlFldkU5SUdub0E1WFROVTJ0RGV2a3JhWEVoS0hZZ3lFY2llYnJSWnRhVERTVkhyMVZ2cDVxZDlVVEIxMW5qYlFHS0N1SXZ5YTRHX21jZkI0QXBlbE03ek1zYk1pdl85MW9zTjhTYUk0enpaRE8wZHZvZjVPcU45QnMwTWN4cG9QdExBcmlJZUhtckVLSEdQcmMyMFlWYXJBekVDNHIwMS12MjdUR19MeHR3N2o0M0d6QQ?oc=5","date":"2026-03-25","type":"regulatory","source":"Barchart.com","summary":"Myasthenia Gravis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Alpine Immune Science, Toleranzia, Cabaletta, Rallybio, Alexion Pharma -","headline":"Myasthenia Gravis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveIn","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcG9wSFhUU3hHYXZpUzZ5TUhFQVJrLWVQV0JVVVZZTXRzUmtTV1lqNFBLTlFtbDlJUkxlTjNDUVFPNVA3UXIzXzNRQ2Nab2RVeXZtbWxqWWZNUlFmZTlrd19zd1BBUUg4TnRibldWYWdZQmxJaXRLT0tnMGticENjdUZ4ME5taHJ5Q0FZanptV2VOX2JDakgtb0RXUG11SDBWbXhXSlBpT2xTVlZOUkRfRXRBSWZvdDBQZWxwY05NdW1WaXN6dW0yU3EtaTlNUXEtZVh3RW5sMTRPMnJubUR2cGd5SHMxLXlGdG40NNIB8gFBVV95cUxPcUczaXZDbjhLU1lLLUFwaURJSDd2Ul9VNlI1YkZlWDhVbWpTSlRZaEgtcE1zdjBMdW5kTzlnVjN3OU5PeVMzbnhjQl8tcElQclRsa2w3dl96d3JESElzc0ZCTzRadDdHNDU1a2hObC1QYmdrYzBVNV9BdU5hTU1Ma1VjQnRqNmFPRE9ZeGNIRVpQYWxkTXpZZmFmbzlMelI2djNnbTB0U0dqRmFCaVBLR29ranNVTXFwVDF6dmV0dkFld0o4S19pTGlTc1JaUDNDRGQ4TGgtR2U4eVZsLTRYWjBUa0FGMUZhVmpsOHo3bE9qdw?oc=5","date":"2026-01-31","type":"pipeline","source":"simplywall.st","summary":"Will Cartesian Therapeutics (NASDAQ:RNAC) Spend Its Cash Wisely? - simplywall.st","headline":"Will Cartesian Therapeutics (NASDAQ:RNAC) Spend Its Cash Wisely?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxNM3hHVGpha2ZsMVAxemxTLUNDazl4el9ZZUhDS0QtMllhamNCLTBEb2ZubjROWXJ0bWRPSUVFLXNRMDJ3cWtKU2tsZG1tM3BxRGdrS3FkYjE3bWU2LUxCTzQ3dWxKbU9YUTJHbThNQVUwWWV3TWpuVlVuTE9idDVHZFlvdEFPNkhpeWtGR3BscFA3QzRaWnlqYldfZWM1OWMzVlRMYmFONXNfT3FyWXdPcGRLQ0twRVpPYzNlYUpKd3JSLWxJOFExc3JXNUNNeFZrOW82OFU2bUNGb2M4QWN4aUNFdmZ3elJvMzgwZHBPNU9BSFR4S0YwSGpTMmhqa0NLVURlYWFacXIxUnhVQlhNU2ljbDIwMHNZWmFOWlhsUUV5cy1QSmR0WjVFaG9lTVN4ekh5a0xKc0ZZQTY1TkhqaF9n?oc=5","date":"2026-01-14","type":"pipeline","source":"GlobeNewswire","summary":"Generalized Myasthenia Gravis Market Outlook Shows Strong - GlobeNewswire","headline":"Generalized Myasthenia Gravis Market Outlook Shows Strong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQMWxKdldmQTZOWk1qWWxuVU53LXd4WkhLRGZRdDFIWTlHMXROY0dqSTVOeld0NWdGM1JhdlVwUC1vem9xRy0wbHV6bks4azZrUVRpaWZjNm5ORFJVZE9pYnhvZF8wOWRVbFVUX2FHUEloMzAwLUlYRjFyWWxIUkV6a0ZFb2RZTlFJWHRMMnkyN1hhR3R0NkVhNElVazhDZw?oc=5","date":"2025-12-18","type":"pipeline","source":"Yahoo Finance","summary":"Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors - Yahoo Finance","headline":"Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE95TFE3ckRvaGFHeFB3TDE4TlRPc3RfTTB2Rm9ZR050RlZ3Q0lVbkVBRDRLOUxnNGEzY09xY3JzcUI5dUhGTTlmdkFhamRLRVNQSnZ4TFA0VDJ4bFpyODdJSElVaHpRVHhsVjFBZ2RBdE5ubG5tLXc?oc=5","date":"2025-11-19","type":"pipeline","source":"labiotech.eu","summary":"Eight CAR-T cell therapy companies you should know about - labiotech.eu","headline":"Eight CAR-T cell therapy companies you should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOZGdsbXducVlCVF92ZzFNN1p6TGZ3NVFPcElGZlJ5cFYxX2tkQVllYkVXREJYYXFjbXNXWmpaNEVoN3cyWk9yVWpDMll0SVB2ZWdkMXd4aGNTTlNiSUZXQVJSZmRnM1EzVWJYVjM4NUNJQk5nSUw1X05XYmQ0MHFWVG9qcUdPRUo4d3FuWUdUNnFXWDVrLWx2X3FlNmE1dUVYZFlXR1JyZWhYR2s?oc=5","date":"2025-10-30","type":"pipeline","source":"citybiz","summary":"Cartesian Therapeutics Appoints Carsten Brunn, Ph.D., as Board Chairman - citybiz","headline":"Cartesian Therapeutics Appoints Carsten Brunn, Ph.D., as Board Chairman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQcTdsYVlJVHNQZUNfejdYdU9weUR0VUlfdkNDVXBnTTJVT2RBa3g2WFNmZUJwUFNzbTVqTWVCSUZHRzMwSTFteUh4NVJDZV9wU2hsQkJaNkNxZXpTdTR5R0MtMmN2Wk1TQjcyRGM3QjQ2S211emhhYnh0bDcweXlBSTFodjFWenVCSDdqVmotSm5sblkzSDJZVzZ1OW52bjNLZ1BLQU1ad3JUM3J2bjUxRTZLbnpCVE9XUXN0WXVJTmp0TUJUVHpIdHFMYnJnRkhnQm1rdUplLUhpSTkxYXFSeDlhTmFQQnBZUTVpMVpiU0t1ODJZUHZvbFNlXzhwak5IblJpcTNEeUpQV1Q1a2Nlb3QzODE?oc=5","date":"2025-10-28","type":"pipeline","source":"PR Newswire","summary":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE52VWVjRkFsTnowbE80ODlyaENkUS1NZl92aVk3QjlqSWZMMzhsbW1FNXhrWmpqVTlhaFd6WGhkQ3BwX2tzeTBKd0xXazdlTi1EX2hR?oc=5","date":"2025-04-08","type":"trial","source":"FirstWord Pharma","summary":"Cartesian's CAR-T therapy shows year-long benefit as Phase III start looms - FirstWord Pharma","headline":"Cartesian's CAR-T therapy shows year-long benefit as Phase III start looms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPaFVNZlg1cVBoWE4xMkthNkNCdloxVWxXdGdBSi1ORDRaVFJDOERTZElHdUg3Rkh3QlJ0S2pyVG1ZX0xzWlpjdW9oLWJ6b3kwYnVwVkdvblNXWlgyS1dXS0Zpa0hMZFcwM1AwMVhoWVFsT2VnRjJkSHhNa0luTDFvQWpucG9JRk5mNExPN3hLUGZhYWpVWWRzUjdhOA?oc=5","date":"2024-07-03","type":"pipeline","source":"The Pharma Letter","summary":"Investors turned off by Cartesian’s news hat-trick - The Pharma Letter","headline":"Investors turned off by Cartesian’s news hat-trick","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPdTVDbnJJMmd4NzdnM2tmRU0zRGNBMXctMUMzRG1PTXZ3U054VjVMalRhbXZGSC1oNFhkSUZXUWxBQ3NDc0hHYjZFcHZwa0hDLWJtZnpzakJGUHEwNTVzNjdPYmVWR1VZdW1lMnVETTI5WXJ0ZlBqS2N5M1VmdHJWZXdtUVBuSDkxcmVHUU9NeXhkLTJTdDJPem1zUG9JZw?oc=5","date":"2024-07-02","type":"trial","source":"BioPharma Dive","summary":"Cartesian data add to progress, questions for CAR-T in autoimmune disease - BioPharma Dive","headline":"Cartesian data add to progress, questions for CAR-T in autoimmune disease","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}